Dirk Jaeger

7.4k citations
90 papers · 4.3k · 2 hit papers · h-index 31

Impact in

  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies
    • CAR-T cell therapy research
  • Immunology top 2%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction

Papers in

Dirk Jaeger

87 papers receiving 4.2k citations

Dirk Jaeger's Hit Papers

CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer 2018 · 471 citations
4710+3+6Years since publication100200300400500

Peers

Dirk Jaeger
Comparison fields: 5 of 104
  • Oncology 3.1k
  • Immunology 1.2k
  • Gastroenterology 213
  • Pulmonary and Respiratory Medicine 1.1k
  • Cancer Research 465
Replace Hong Jae Chon with:
Hong Jae Chon South Korea
Hiroshi Kurahara Japan
Alexander Quaas Germany
Magali Svrcek France
Dirk Jäger Germany
Martina Mirlacher Switzerland
Alexander N. Shoushtari United States
Eishi Nagai Japan
Maximilian Bockhorn Germany
Zhaode Bu China
Dirk Jaeger relative to Hong Jae Chon South Korea Hong Jae Chon's profile →
Citations per field
00.5×11.6×
Hong Jae Chon · 1×
Citations per year

Countries citing papers authored by Dirk Jaeger

Since Specialization
Citations

This map shows the geographic impact of Dirk Jaeger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Jaeger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Jaeger more than expected).

Fields of papers citing papers by Dirk Jaeger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Jaeger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Jaeger. The network helps show where Dirk Jaeger may publish in the future.

Co-authors

The 25 scholars most cited alongside Dirk Jaeger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dirk Jaeger Line = papers co-authored together Dirk Jaeger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial
Hit paper breakdown →
2016511
2
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
Hit paper breakdown →
2018471
3 2011321
4 2007195
5 2019172
6 2009171
7 2004152
8 2015134
9 2013131
10 2017120
11 2020110
12 2018109
13 2011101
14 201793
15 201886
16 201680
17 202277
18 201377
19 201668
20 202161

About Dirk Jaeger

Dirk Jaeger is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Surgery and Molecular Biology, having authored 90 papers that have together received 4.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (27 papers), Colorectal Cancer Treatments and Studies (17 papers), Immunotherapy and Immune Responses (13 papers), Gastric Cancer Management and Outcomes (10 papers), Lung Cancer Research Studies (9 papers), Immune Cell Function and Interaction (7 papers), Neuroendocrine Tumor Research Advances (7 papers) and Cancer Research and Treatments (6 papers). The work is most often cited by research in Oncology (3.1k citations), Immunology (1.2k citations), Gastroenterology (213 citations), Pulmonary and Respiratory Medicine (1.1k citations) and Cancer Research (465 citations). Dirk Jaeger has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Niels Halama, Dung T. Le, Emiliano Calvo, Patrick A. Ott, Filippo de Braud, Padmanee Sharma, Joseph W. Kim, Marina Tschaika, Inka Zoernig and Johanna C. Bendell. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, PLoS ONE, OncoImmunology and Journal of Nuclear Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact